Tag: Firibastat
Quantum Genomics revokes its historic boss and abandons firibastat in cardiology – 02/22/2023 at 18:21
(AOF) – Quantum Genomics, a biotech developing drugs that act directly on the brain, announces that its managing director since 2018 Jean-Philippe Milon has also been appointed chairman of the…
Quantum Genomics: will present the results of Firibastat – 09/26/2022 at 10:45
(CercleFinance.com) – Quantum Genomics announces that the presentation of the results of its phase III FRESH study, in resistant hypertension, will finally take place on November 7, 2022. This presentation…
Quantum Genomics: will present the results of Firibastat
(CercleFinance.com) – Quantum Genomics announces that the presentation of the results of its phase III FRESH study, in resistant hypertension, will finally take place on November 7, 2022. This presentation…
QUANTUM GENOMICS: Quantum Genomics announces that the presentation of the results of Firibastat, in its FRESH phase III study, will finally take place on November 7, 2022 as part of a session dedicated to resistant hypertension during the AHA congress. – 26/09/2022 at 07:30
Quantum Genomics announces that the presentation of the results of the Firibastat, in its phase III FRESH study, will finally take place on November 7, 2022 as part of a…